NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. MABTHERA IV NHL AND CLL 160310 For the treatment of Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukaemia pronounced (mab-thir-ra) contains the active ingredient rituximab (rch) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about MabThera intravenous infusion.It […]
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. THIOPRINE 50 azathioprine film-coated tablets Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Thioprine 50. It does not contain all the available information. It does not take the place of talking to your doctor or […]
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. REBIF® Interferon beta – 1a (rch) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about REBIF. It does not contain all of the available information. It does not take the place of talking to your doctor […]
A first-of-its-kind contraceptive developed at the University of Illinois Chicago has been approved by the U.S. Food and Drug Administration. The new contraceptive, called Phexxi, is a non-hormonal vaginal gel that can be used on-demand to prevent pregnancy. The contraceptive is the fourth drug developed by researchers at UIC to achieve FDA approval. This milestone […]
